According to Aptorum Group 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 23.4737. At the end of 2022 the company had a P/S ratio of 15.2.
Year | P/S ratio | Change |
---|---|---|
2022 | 15.2 | -56.27% |
2021 | 34.7 | -62.39% |
2020 | 92.2 | -89.28% |
2019 | 860 | -25.03% |
2018 | > 1000 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.9848 | -95.80% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 92.5 | 294.05% | ๐บ๐ธ USA |